Intelligent Bio Solutions (NASDAQ:INBS) Trading 0.3% Higher

Intelligent Bio Solutions Inc. (NASDAQ:INBS – Get Rating)’s share price traded up 0.3% during mid-day trading on Tuesday . The company traded as high as $6.42 and last traded at $5.93. 28,133 shares traded hands during mid-day trading, a decline of 88% from the average session volume of 242,778 shares. The stock had previously closed at $5.91.

Intelligent Bio Solutions Trading Up 0.3 %

The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.19 and a current ratio of 1.32. The business’s 50-day simple moving average is $2.84.

Intelligent Bio Solutions (NASDAQ:INBS – Get Rating) last issued its quarterly earnings results on Tuesday, February 14th. The company reported ($0.46) earnings per share (EPS) for the quarter. The business had revenue of $0.63 million during the quarter. Intelligent Bio Solutions had a negative return on equity of 65.81% and a negative net margin of 421.22%. As a group, equities research analysts expect that Intelligent Bio Solutions Inc. will post -6.6 earnings per share for the current fiscal year.

About Intelligent Bio Solutions

(Get Rating)

Intelligent Bio Solutions Inc, a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.